Literature DB >> 164552

Distinction between Duchenne and other muscular dystrophies by ribosomal protein synthesis.

V Ionasescu.   

Abstract

Ribosome concentration, ribosome distribution on sucrose density gradients, and in-vitro ribosomal amino-acid incorporation (noncollagen and collagen synthesis) were studied in muscle biopsy samples obtained from 30 patients with Duchenne muscular dystrophy, seven patients with Becker muscular dystrophy, and 10 with facioscapulohumeral muscular dystrophy. Ribosome concentration was normal in Duchenne and facioscapulohumeral and decreased in Becker muscular dystrophy. Distribution of ribosomes in sucrose density gradients showed abnormalities (sharp monosomal peak and fewer polyribosomes) only in Duchenne muscular dystrophy and was normal in the other two types. In-vitro amino-acid incorporation of ribosomes in Duchenne muscular dystrophy revealed high collagen and low noncollagen synthesis of the heavy polyribosomes. This abnormality is controlled by an undetermined enzymatic factor belonging to the soluble enzyme fraction. Supplementation of the dystrophic heavy polyribosomes with normal soluble enzymes restored the synthesis of collagen to that of the controls. Heavy polyribosomes extracted from normals or from carriers produce proportionately more collagen in the presence of soluble enzyme fraction from Duchenne muscular dystrophy than in the presence of their homologous enzymes. In Becker muscular dystrophy, both noncollagen and collagen synthesis of the heavy polyribosomes were increased, under the influence of ribosomal factors. The different protein synthesis in Duchenne and Becker muscular dystrophies suggests that these conditions are non-allelic. In facioscapulohumeral muscular dystrophy the changes in protein synthesis occurred only in the early stage of the disease and consisted of increased noncollagen synthesis of the light polyribosomes, while the heavy polyribosomes had normal activity including collagen synthesis. This reaction was controlled by ribosomal factors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164552      PMCID: PMC1013230          DOI: 10.1136/jmg.12.1.49

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  5 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Identification of carriers of Duchenne muscular dystrophy by muscle protein synthesis.

Authors:  V Ionasescu; H Zellweger; P Shirk; T W Conway
Journal:  Neurology       Date:  1973-05       Impact factor: 9.910

3.  Abnormal protein synthesis in facioscapulohumeral muscular dystrophy.

Authors:  V Ionasescu; H Zellweger; P Shirk; T W Conway
Journal:  Neurology       Date:  1972-12       Impact factor: 9.910

4.  The linkage relations of the loci for benign (Becker type) X-borne muscular dystrophy, colour blindness and the Xg blood groups.

Authors:  A E Emery; C A Smith; R Sanger
Journal:  Ann Hum Genet       Date:  1969-01       Impact factor: 1.670

5.  Genetic linkage between the loci for colour blindness and Duchenne type muscular dystrophy.

Authors:  A E Emery
Journal:  J Med Genet       Date:  1966-06       Impact factor: 6.318

  5 in total
  4 in total

1.  Facioscapulohumeral muscular dystrophy concentrated in the village Cullar, Nevşehir, Turkey.

Authors:  B S Sayli; K Yaltkaya; S Cin
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.

Authors:  R O McKeran; D Halliday; P Purkiss
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-10       Impact factor: 10.154

3.  3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease.

Authors:  R O McKeran; D Halliday; P Purkiss; P Royston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-06       Impact factor: 10.154

4.  RNA helicase, DDX27 regulates skeletal muscle growth and regeneration by modulation of translational processes.

Authors:  Alexis H Bennett; Marie-Francoise O'Donohue; Stacey R Gundry; Aye T Chan; Jeffrey Widrick; Isabelle Draper; Anirban Chakraborty; Yi Zhou; Leonard I Zon; Pierre-Emmanuel Gleizes; Alan H Beggs; Vandana A Gupta
Journal:  PLoS Genet       Date:  2018-03-08       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.